Author:
Sameen Sheema,Barbuti Roberto,Milazzo Paolo,Cerone Antonio
Publisher
Springer International Publishing
Reference39 articles.
1. WHO/Europe—Colorectal cancer.
http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/news/news/2012/2/early-detection-of-common-cancers/colorectal-cancer
2. Deschoolmeester, V., Baay, M., Specenier, P., Lardon, F., Vermorken, J.B.: A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist 15, 699–731 (2010)
3. Repetto, L., Gianni, W., Aglianò, A.M., Gazzaniga, P.: Impact of EGFR expression on colorectal cancer patient prognosis and survival: a response. Ann. Oncol. 16, 1557 (2005)
4. Gschwind, A., Fischer, O.M., Ullrich, A.: The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer. 4, 361–370 (2004)
5. Van Cutsem, E., Peeters, M., Siena, S., Humblet, Y., Hendlisz, A., Neyns, B., Canon, J.L., Van Laethem, J.L., Maurel, J., Richardson, G., Wolf, M., Amado, R.G.: Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J. Clin. Oncol. 25, 1658–1664 (2007)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献